Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 9,707 shares at $25.22 ($248K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Scheduled sale ($248k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.22 | 3,776 | $95K | 38.4% |
| 2 | $25.22 | 3,776 | $95K | 38.4% |
| 3 | $26.02 | 1,455 | $38K | 15.3% |
| 4 | $27.54 | 600 | $17K | 6.7% |
| 5 | $29.35 | 100 | $3K | 1.2% |
| Total | $25.53 avg | 9,707 |
| $248K |
| 100% |
| Filing → |
| STOK | SELL | 2026-08-18 | $153K | — | Filing → |
| STOK | SELL | 2026-08-05 | $208K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |